Literature DB >> 19610077

Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health.

Laurent Peyrin-Biroulet1, Alarcos Cieza, William J Sandborn, Nenad Kostanjsek, Michael A Kamm, Toshifumi Hibi, Marc Lémann, Gerold Stucki, Jean-Frédéric Colombel.   

Abstract

The inflammatory bowel diseases (IBDs) are associated with a reduced quality of life. The impact of IBD on disability remains largely unknown. With the International Classification of Functioning, Disability, and Health (ICF) of the World Health Organization (WHO), we can now rely on a globally agreed-upon framework and system for classifying the typical spectrum of problems in the functioning of persons with a specific disease given the environmental context in which they live. The aim of this article is to outline the methods to be utilized to develop ICF Core Sets for IBD. The project is a cooperation between the ICF Research Branch of the WHO, the IPNIC group, the International Society of Physical Rehabilitation Medicine (ISPRM), and the International Organization on Inflammatory Bowel Disease (IOIBD). Four worldwide studies will be conducted from 2009 to 2010. ICF categories relevant for IBD will be identified by systematic literature review of outcomes and measures used in IBD research, semistructured patient interviews, Internet-based expert survey, and cross-sectional study for clinical applicability. The final definition of ICF Core Sets for IBD will be determined at a Consensus Conference. Field testing will then be used to validate the ICF Core Sets. ICF Core Sets are being designed to provide useful standards for research and clinical practice. This tool will enable research that improves understanding of functioning, disability, and health in IBD, and may lead to interventions to improve and maintain functioning and minimize disability among IBD patients throughout the world.

Entities:  

Mesh:

Year:  2010        PMID: 19610077     DOI: 10.1002/ibd.21010

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  22 in total

1.  Why should we define and target early Crohn's disease?

Authors:  Laurent Peyrin-Biroulet
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

Review 2.  Patient-reported outcome measures in inflammatory bowel disease.

Authors:  Wael El-Matary
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

3.  Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Authors:  Cécile Campos; Antoine Perrey; Céline Lambert; Bruno Pereira; Marion Goutte; Anne Dubois; Felix Goutorbe; Michel Dapoigny; Gilles Bommelaer; Constance Hordonneau; Anthony Buisson
Journal:  Dig Dis Sci       Date:  2017-04-11       Impact factor: 3.199

Review 4.  Impact of inflammatory bowel disease on disability.

Authors:  Katharina Büsch; Amnon Sonnenberg; Nick Bansback
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 5.  Preventing disability in inflammatory bowel disease.

Authors:  Patrick B Allen; Corinne Gower-Rousseau; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Therap Adv Gastroenterol       Date:  2017-10-16       Impact factor: 4.409

6.  Examining Psychosocial Mechanisms of Pain-Related Disability in Inflammatory Bowel Disease.

Authors:  Katherine M Fretz; Dean A Tripp; Laura Katz; Mark Ropeleski; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2020-03

Review 7.  First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

Authors:  Laurent Peyrin-Biroulet; Gionata Fiorino; Anthony Buisson; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

8.  Experiences of patients with chronic gastrointestinal conditions: in their own words.

Authors:  Jennifer B McCormick; Rachel R Hammer; Ruth M Farrell; Gail Geller; Katherine M James; Edward V Loftus; Mary Beth Mercer; Jon C Tilburt; Richard R Sharp
Journal:  Health Qual Life Outcomes       Date:  2012-03-08       Impact factor: 3.186

9.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325

10.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health.

Authors:  Laurent Peyrin-Biroulet; Alarcos Cieza; William J Sandborn; Michaela Coenen; Yehuda Chowers; Toshifumi Hibi; Nenad Kostanjsek; Gerold Stucki; Jean-Frédéric Colombel
Journal:  Gut       Date:  2011-06-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.